October 22, 2014

Cavan Appoints Matthew Harvey as Director of Research and Development Further Strengthening Genetics and Cannabinoid Expertise

Yahoo! Finance Canada
CAVAN VENTURES INC. (TSX VENTURE: CVN) ("Cavan" or "the Company") is pleased to provide a corporate update regarding the continuing exploration of the potential Hemp/Cannabinoid industry.

Cavan Ventures Inc. previously announced (see news release dated 2014-03-25) the diversification of its growth plan into the Medical Marijuana and Hemp industry. To accelerate this process Matthew Harvey has been appointed Director of Research and Development with exclusivity to the company.

Mr. Harvey has been a master grower and in the industry since the mid 1990's with worldwide exposure since 2004. Mr. Harvey is the Founder and CEO of BC Bud Depot ("BCBD"), a producer of marijuana seeds. BCBD takes pride in developing its award winning THC and CBD cannabis strains. During Mr. Harvey's tenure, BCBD has received over 21 Cannabis Cup awards, including 7 first place awards, 9 Top Strain awards, 6 top 3 strain awards and an induction in 2009 to the Seed Bank Hall of Fame award. Most recently, Mr. Harvey has steered BCBD towards a new developmental approach to medicinal genetics, Cannabinoid sciences and CBD proprietary strains.

No comments:

Post a Comment